Artificial intelligence is poised to revolutionise cancer treatment, according to Rene Haas, the CEO of Arm Holdings, the UK’s largest tech firm. Haas predicts that in our lifetime, AI will tackle the currently unsolvable complexity of DNA markers affected by cancer.
The Potential of AI in Healthcare
In a podcast interview, Haas expressed his belief that with increasingly sophisticated computing capabilities, AI will eventually be able to model complex biological processes to find a cure for cancer. He highlighted that today’s challenge—understanding how DNA markers interact with cancer—is beyond human and existing computer abilities. His firm, Arm Holdings, designs central processing units (CPUs) for microchips in billions of global devices, making them a crucial player in the AI sector.
Professor Chris Bakal from the Institute of Cancer Research in London echoed Haas’s enthusiasm for AI in medical research. He argued that the key is providing AI with precise and relevant data, a practice already in place by his firm, Sentinal4D, which uses data from patient samples rather than general internet-sourced data. According to Bakal, the right measurements could expedite treatment development significantly, offering tangible benefits to patients.
A Growing Demand for Robotics and Chips
Haas envisions a future where AI-driven humanoid robots become part of everyday life, particularly in industries like manufacturing and service sectors, within the next five years. However, expansion has been held back by a shortage of the necessary chips to build data centres. Arm’s technology, already powering half of the world’s AI data centres, is central to this evolution, indicating vast potential for growth as the demand for their chips continues to soar.
Despite the growth opportunities, Haas is sceptical about the possibility of the UK establishing chip manufacturing facilities, which are currently dominated by Taiwanese giant TSMC. He cites the high costs, expertise requirements, and the extensive ecosystem needed for such ventures, making UK-based fabs unlikely.
Economic Implications and Market Dynamics
Discussing the impact of AI on employment, Haas believes that fears of job losses due to AI are exaggerated. While changes in the workforce are anticipated, he suggests that new opportunities created by AI will outweigh jobs displaced by automation. Additionally, concerns about AI’s influence on stock market trends are similarly overstated, as long-term demand is expected to remain strong.
With Arm Holdings taking significant strides in AI technology, Haas emphasizes the sustained presence of the company in the UK, stating that a substantial portion of its workforce remains based in Cambridge. Arm’s continuing involvement in the tech sector, alongside support from major firms like Facebook-owner Meta, underscores its pivotal role in the ongoing AI revolution.
Reporting based on coverage first published by bbc.co.uk.